IHH Healthcare's Long-Term Prospects Still Bright -- Market Talk

Dow Jones08-30

0229 GMT - IHH Healthcare's long-term prospects still look positive, RHB IB analyst Oong Chun Sung writes in a research report as he raises the stock's target price to MYR8.00 from MYR7.90. If the healthcare provider hits its bed expansion target of 4,000 beds by 2028, it can tap into regions where quality healthcare is scarce, Oong says. RHB IB also likes IHH's reputable footprint across key markets and focus on affluent clients, which offer earnings resiliency. RHB IB maintains a buy rating on the stock, which is up 0.2% at MYR6.30.(amanda.lee@wsj.com)

 

(END) Dow Jones Newswires

August 29, 2024 22:40 ET (02:40 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment